PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35129440-7	2022	As previous studies reported that tacrolimus treatment lead to a decrease of the measured plasma activity of lipoprotein lipase (LPL), we hypothesized that tacrolimus or related metabolites could also interfere by direct inhibition of LPL involved in TG analytical method used.	Tacrolimus	34-44	lipoprotein lipase	Homo sapiens	109-127	
35129440-7	2022	As previous studies reported that tacrolimus treatment lead to a decrease of the measured plasma activity of lipoprotein lipase (LPL), we hypothesized that tacrolimus or related metabolites could also interfere by direct inhibition of LPL involved in TG analytical method used.	Tacrolimus	34-44	lipoprotein lipase	Homo sapiens	129-132	
35129440-7	2022	As previous studies reported that tacrolimus treatment lead to a decrease of the measured plasma activity of lipoprotein lipase (LPL), we hypothesized that tacrolimus or related metabolites could also interfere by direct inhibition of LPL involved in TG analytical method used.	Tacrolimus	34-44	lipoprotein lipase	Homo sapiens	235-238	
35129440-7	2022	As previous studies reported that tacrolimus treatment lead to a decrease of the measured plasma activity of lipoprotein lipase (LPL), we hypothesized that tacrolimus or related metabolites could also interfere by direct inhibition of LPL involved in TG analytical method used.	Tacrolimus	156-166	lipoprotein lipase	Homo sapiens	109-127	
35129440-7	2022	As previous studies reported that tacrolimus treatment lead to a decrease of the measured plasma activity of lipoprotein lipase (LPL), we hypothesized that tacrolimus or related metabolites could also interfere by direct inhibition of LPL involved in TG analytical method used.	Tacrolimus	156-166	lipoprotein lipase	Homo sapiens	129-132	
35129440-7	2022	As previous studies reported that tacrolimus treatment lead to a decrease of the measured plasma activity of lipoprotein lipase (LPL), we hypothesized that tacrolimus or related metabolites could also interfere by direct inhibition of LPL involved in TG analytical method used.	Tacrolimus	156-166	lipoprotein lipase	Homo sapiens	235-238	
19584682-0	2009	Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations.	Tacrolimus	0-10	lipoprotein lipase	Homo sapiens	151-169	
18448283-9	2008	LPL activity in post-heparin normal human plasma was suppressed following the co-incubation with CsA, RAPA, FK-506 or MMF whereas HL activity remained unaffected.	Tacrolimus	108-114	lipoprotein lipase	Homo sapiens	0-3